318 filings
Page 3 of 16
UPLOAD
kz5eghkj91gc9jnt5
1 Dec 17
Letter from SEC
12:00am
CORRESP
2ysvl4l9b74yj3s5uj7b
30 Nov 17
Correspondence with SEC
12:00am
424B4
de7ioz
29 Nov 17
Prospectus supplement with pricing info
12:00am
UPLOAD
aolfh5sqqxum
29 Nov 17
Letter from SEC
12:00am
EFFECT
0cvslf14ctsn
27 Nov 17
Notice of effectiveness
12:00am
UPLOAD
wlhtdvsrdg
22 Nov 17
Letter from SEC
12:00am
CORRESP
psia6n5fuf
22 Nov 17
Correspondence with SEC
12:00am
8-K
e6dotnha mz80g
17 Nov 17
Anthera Pharmaceuticals Announces Expected Receipt of Nasdaq Listing Determination Notice
12:00am
D
zzyg3fisb
9 Nov 17
$2.88M in equity / options, sold $2.88M, 21 investors
12:00am
8-K
j0j2j
6 Nov 17
Anthera Pharmaceuticals Provides Business Update
12:00am
8-K
lipbmfliuf8ou6y97jqj
25 Oct 17
Anthera Pharmaceuticals Announces Pricing of $15 Million Private Placement Offering
12:00am
8-K
zbbotzbk1ldhqg339
28 Aug 17
Anthera Announces Top Line Final Data from the Extension Period of the Phase 2 BRIGHT-SC Study of Blisibimod in Patients with IgA Nephropathy
12:00am
8-K
id1epwkzzbq gvf
9 Aug 17
Anthera Pharmaceuticals Provides Business Update
12:00am
8-K
bzbjp5as7yb63zsh8xdt
9 Aug 17
Other Events
12:00am